Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VRTX | REGN |
|---|---|---|
| Price | $521.79 | $794.67 |
| Change today | ▲ 1.05% | ▼ 0.89% |
| Market cap | $132.25B | $81.81B |
| Return, 3 months | +9.8% | +27.6% |
| Return, year to date | +15.1% | +3.4% |
| Return, 1 year | +38.5% | +38.4% |
| P/E (TTM) | 30.4 | 19.7 |
| P/B | 6.5 | 2.6 |
| P/E percentile vs own 5y | 79th | 63rd |
| Dividend yield | – | 0.46% |
| Revenue growth (YoY, latest qtr) | +12.5% | +16.7% |
| Net profit growth (YoY) | +6.5% | -6.8% |
| Gross margin | 86.0% | 84.9% |
| Operating margin | 37.9% | 26.9% |
| Net margin | 35.0% | 27.9% |
| Return on equity | 23.5% | 14.0% |
| Analyst target vs. price | +11.0% | +5.9% |
| Analyst buy share | 88% | 63% |
| RSI (14) | 50 | 53 |
| 30-day volatility | 25.7% | 26.4% |
| Max drawdown, 1 year | -15.2% | -25.9% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.